128 related articles for article (PubMed ID: 31333109)
1. Non-linear Relationship between Tacrolimus Blood Concentration and Acute Rejection After Kidney Transplantation: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies.
Yin S; Song T; Li X; Xu H; Zhang X; Jiang Y; Lin T
Curr Pharm Des; 2019; 25(21):2394-2403. PubMed ID: 31333109
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics.
Israni AK; Riad SM; Leduc R; Oetting WS; Guan W; Schladt D; Matas AJ; Jacobson PA;
Transpl Int; 2013 Oct; 26(10):982-9. PubMed ID: 23879408
[TBL] [Abstract][Full Text] [Related]
3. Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies.
Vadcharavivad S; Saengram W; Phupradit A; Poolsup N; Chancharoenthana W
Drugs; 2019 Dec; 79(18):1947-1962. PubMed ID: 31713065
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus Trough Levels as a Risk Factor for Acute Rejection in Renal Transplant Patients.
Arreola-Guerra JM; Serrano M; Morales-Buenrostro LE; Vilatobá M; Alberú J
Ann Transplant; 2016 Feb; 21():105-14. PubMed ID: 26879833
[TBL] [Abstract][Full Text] [Related]
5. Is There a Temporal Relationship Between Trough Whole Blood Tacrolimus Concentration and Acute Rejection in the First 14 Days After Kidney Transplantation?
Hu R; Barratt DT; Coller JK; Sallustio BC; Somogyi AA
Ther Drug Monit; 2019 Aug; 41(4):528-532. PubMed ID: 31259882
[TBL] [Abstract][Full Text] [Related]
6. Higher tacrolimus trough levels and time in the therapeutic range are associated with the risk of acute rejection in the first month after renal transplantation.
Nguyen TVA; Nguyen HD; Nguyen TLH; Le VT; Nguyen XK; Tran VT; Le DT; Ta BT
BMC Nephrol; 2023 May; 24(1):131. PubMed ID: 37158838
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
[TBL] [Abstract][Full Text] [Related]
8. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus Trough Level at the First Month May Predict Renal Transplantation Outcomes Among Living Chinese Kidney Transplant Patients: A Propensity Score-Matched Analysis.
Yin S; Song T; Jiang Y; Li X; Fan Y; Lin T
Ther Drug Monit; 2019 Jun; 41(3):308-316. PubMed ID: 31083041
[TBL] [Abstract][Full Text] [Related]
10. Pretransplant Tacrolimus Dose Requirements Predict Early Posttransplant Dose Requirements in Blood Group AB0-Incompatible Kidney Transplant Recipients.
Shuker N; de Man FM; de Weerd AE; van Agteren M; Weimar W; Betjes MG; van Gelder T; Hesselink DA
Ther Drug Monit; 2016 Apr; 38(2):217-22. PubMed ID: 26630539
[TBL] [Abstract][Full Text] [Related]
11. No Significant Influence of Reduced Initial Tacrolimus Dose on Risk of Underdosing and Early Graft Function in Older and Overweight Kidney Transplant Recipients.
Krzyżowska K; Kolonko A; Giza P; Chudek J; Więcek A
Transplant Proc; 2018; 50(6):1755-1759. PubMed ID: 30056895
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tacrolimus and cyclosporine for immunosuppression after renal transplantation: An updated systematic review and meta-analysis.
Azarfar A; Ravanshad Y; Mehrad-Majd H; Esmaeeli M; Aval SB; Emadzadeh M; Salehi M; Moradi A; Golsorkhi M; Khazaei MR
Saudi J Kidney Dis Transpl; 2018; 29(6):1376-1385. PubMed ID: 30588970
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
[TBL] [Abstract][Full Text] [Related]
14. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection.
Darley DR; Carlos L; Hennig S; Liu Z; Day R; Glanville AR
Eur J Clin Pharmacol; 2019 Jul; 75(7):879-888. PubMed ID: 30859243
[TBL] [Abstract][Full Text] [Related]
16. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
[TBL] [Abstract][Full Text] [Related]
17. Monitoring intracellular tacrolimus concentrations and its relationship with rejection in the early phase after renal transplantation.
Francke MI; Andrews LM; Lan Le H; van de Velde D; Dieterich M; Udomkarnjananun S; Clahsen-van Groningen MC; Baan CC; van Gelder T; de Winter BCM; Hesselink DA
Clin Biochem; 2022 Mar; 101():9-15. PubMed ID: 34890583
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients.
Sun Q; Liu ZH; Yin G; Chen H; Chen J; Ji S; Li LS
Nephrol Dial Transplant; 2006 Feb; 21(2):510-7. PubMed ID: 16421166
[TBL] [Abstract][Full Text] [Related]
19. Higher tacrolimus trough levels on days 2-5 post-renal transplant are associated with reduced rates of acute rejection.
O'Seaghdha CM; McQuillan R; Moran AM; Lavin P; Dorman A; O'Kelly P; Mohan DM; Little P; Hickey DP; Conlon PJ
Clin Transplant; 2009; 23(4):462-8. PubMed ID: 19681975
[TBL] [Abstract][Full Text] [Related]
20. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
